Splenz Pharmaceuticals Private Limited, a active private limited company, was established on 27 May 2014 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52599PN2014PTC151314. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Ashish Bhagwan Bhagat (Director), Jitendra Ashok Fasate (Director). Past directors included Padmakumar Poduvattil, Shylaja Padmakumar, Ashish Bhagwan Bhagat. It holds ₹5.99 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki,, Pune, Maharashtra, 412308.
U52599PN2014PTC151314
151314
27 May 2014
₹2.00 M
₹2.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Splenz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Bhagwan Bhagat | Director | 23 Sep 2015 | Current |
| Jitendra Ashok Fasate | Director | 23 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Aug 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2015 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Splenz Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.48% increase. The company also saw a substantial improvement in profitability, with a 77.22% increase in profit. The company's net worth Soared by an impressive increase of 19.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Splenz Pharmaceuticals had a public holding of 14.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,990,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2020 | The South Indian Bank Limited | ₹5.99 M | Open |
| 06 Dec 2014 | Others | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Splenz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Splenz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Splenz Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Splenz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Splenz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
The activity A charge registered on 06 Dec 2014 via Charge ID 10535157 with Others was fully satisfied on 31 Jul 2020. was completed.
A charge with The South Indian Bank Limited of Rs. 5.99 M registered on 03 Jan 2020 with Charge ID 100318836 was modified on 03 Jul 2020. was recorded as a recent event.
Progress on A charge with The South Indian Bank Limited amounted to Rs. 5.99 M with Charge ID 100318836 was registered on 03 Jan 2020. was documented.
A charge with Others of Rs. 5.00 M registered on 06 Dec 2014 with Charge ID 10535157 was modified on 10 Jul 2018. was recorded as a recent event.
The CIN of Splenz Pharmaceuticals Private Limited is U52599PN2014PTC151314.
Splenz Pharmaceuticals Private Limited is headquartered at S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki,, Pune, Maharashtra, 412308.
Splenz Pharmaceuticals Private Limited was incorporated on 27 May 2014.
The current directors of Splenz Pharmaceuticals Private Limited are
The primary industry of Splenz Pharmaceuticals Private Limited is Trade.
Splenz Pharmaceuticals Private Limited is unlisted.
The authorized capital of Splenz Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Splenz Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX